ECTRIMS 2014

  • Innovation and Optimization: Engaging today's patients 30-10-2014

    • ECTRIMS 2014 - Innovation and Optimization: Engaging today's patients

      The Satellite Symposium Innovation and Optimization: Engaging today's patients, will be published in 7 parts. These are the first 3.

      Patients with multiple sclerosis (MS) want to be actively engaged in their treatment decisions, which will help their long-term health and medication adherence, according to speakers at the “Innovation and Optimization: Engaging Today’s Patients” talk at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.

    • Douglas Goodin - Douglas Goodin - Welcome

    • David Bates - David Bates - Introduction

    • Peter Rieckmann - Peter Rieckmann - Multiple Sclerosis in the 21st century

  • Grant for Multiple Sclerosis Innovation Award 30-10-2014

    • ECTRIMS 2014 - Grant for Multiple Sclerosis Innovation Award

      The innovation grant is awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes.

    • Professor David Bates - Introduction

    • Steven Hildemann - Our commitment to multiple sclerosis

    • Professor David Bates - Updates on the GMSI 2013 award winners

    • Carlos Matute - Recipient of the GMSI 2014 award

ECTRIMS 2013: Supporting patient engagement for optimized treatment management in MS

  • Satellite symposium 02-10-2013

    • ECTRIMS 2013

      There is more to caring for MS patients than prescribing drugs: The collaboration between clinical professionals and MS patients is vital. The patient should be engaged in decision making and clinicians should keep communicating and take note of their specific aims, hopes, and plans. These issues are discussed in detail by Prof. Mark S. Freedman, Dr. Anthony Feinstein, and Dr. Alessandra Lugaresi.

    • Anthony Feinstein - Understanding our patients: the importance of effective communication

    • Alessandra Lugaresi - Engaging with patients to achieve treatments goals

    • David Bates - Discussion: patient engagement with MS treatment

back to top

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

Prof Timothy Vartanian

Prof Timothy Vartanian

Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell University, obtained his M.D. degree from the University of Chicago, Pritzker School of Medicine and his Ph.D. in Biochemistry and Molecular Biology from the ...

Read more »

Journal Editor's choice

Multiple Sclerosis and Related Disorders ; Volume 3, Issue 2

Prof. Gavin Giovannoni

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
D.R. Altmann, K. Schmierer, K. Hunter, D.J. Tozer, C.A. Wheeler-Kingshott, A. Coles, D.H. Miller
Multiple Sclerosis and Related Disorders, April 2014, Vol 3 Issue 2.

Read more »

back to top